Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

Journal of Clinical Oncology

Volumn 18, Issue 4, 2000, Pages 716-723

  Tulpule, Anil ^a   Scadden, David T ^a   Espina, Byron M ^a   Cabriales, Suzanne ^a   Howard, Walter ^a   Shea, Kathleen ^a   Gill, Parkash S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IM 682; IM 862; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TINGLING;

EID: 0033957239     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.4.716     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report (February 1993). Atlanta, GA, Centers for Disease Control and Prevention, 1993, pp 1-23
2. Gill PS, Hamilton AW, Naidu Y: Epidemic (AIDS-related) Kaposi's sarcoma: Epidemiology, pathogenesis, and treatment. AIDS Updates 7:1-11, 1994
3. Evans LM, Itri LM, Campion M, et al: Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother 10:39-50, 1991
4. Laubenstein LJ, Kriegel RL, Odajnk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115-1120, 1984
5. Gill PS, Rarick MU, McCutchan JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90:427-433, 1991
6. Saville MW, Lietzau J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995
7. Gill PS, Wernz J, Scadden DT, et al: Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma. J Clin Oncol 14:2353-2364, 1996
8. Stewart S, Jablonski H, Goebel FD, et al: Randomized comparative trial of pegylated liposomal doxorubincin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 16:683-691, 1998
9. Tulpule A, Espina BM, Cabriales S, et al: IM-862 nasal solution is an active antiangiogenic agent in the treatment of AIDS-related Kaposi's sarcoma. Proc Am Soc Clin Oncol 18:535a, 1999 (abstr 2065)
10. IM862 [investigator's brochure] (ed 6): August 1, 1998. Kirland, WA, Cytran Inc, 1998
11. Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma and the acquired immunodeficiency syndrome: A proposal for a uniform evaluation, response and staging criteria. J Clin Oncol 7:1201-1207, 1989
12. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:239-253, 1992
13. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc 78:427-434, 1983
14. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 1980
15. Lunardi-Iskandar, Gill PS, Lam VH, et al: Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst 87:974-981, 1995
16. Louie S, Cai J, Law R, et al: The effect of interleukin-1 and interleukin-1 antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 4:455-460, 1995
17. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al: AIDS-Kaposi's sarcoma-derived cells produce and respond to interleukin-6. Proc Natl Acad Sci U S A 87:4068-4072, 1990
18. Nair BC, DeVico AL, Nakamura S, et al: Identification of major growth factor for AIDS-KS cells as oncostatin-M. Science 255:1430-1432, 1992
19. Ensoli B, Barillari G, Gallo RC: Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 127:147-155, 1992
20. Masood R, Cai J, Zheng T, et al: Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in as autocrine growth factor for AIDS-KS. Proc Natl Acad Sci U S A 94:979-984, 1997
21. Mihalcea AM, Smith DL, Monini P, et al: Treatment update for AIDS-related Kaposi's sarcoma. AIDS 13:S215-S225, 1999 (suppl A)
22. Pluda JM, Shay LE, Foli A, et al: Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst 85:1585-1592, 1993
23. Schwartsmann G, Sprinz E, Kalakun L, et al: Phase II study of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcoma. Tumori 82:360-363, 1996
24. Eckhardt SG, Burris HA, Eckhardt JR, et al: A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium. Ann Oncol 7:491-496, 1996
25. Tulpule A, Snyder JC, Espina BM, et al: A phase I study of tecogalan, a novel angiogenesis inhibitor in the treatment of AIDS-related Kaposi's sarcoma and solid tumors. Blood 84:248a, 1994 (suppl 1) (abstr)
26. Dezube BJ, VonRoenn JH, Holden-Wiltse J, et al: Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trials Group Study. J Clin Oncol 16:1444-1449, 1998
27. Twardowski P, Gradishar WJ: Clinical trials of antiangiogenic agents. Curr Opin Oncol 9:584-589, 1997
28. Rabkin CS, Testa MA, Fischl MA, et al: Declining incidence of Kaposi's sarcoma in AIDS Clinical Trials Group (ACTG) Trials. J Acquir Immune Defic Syndr Hum Retrovirol 17:A39, 1988 (abstr)
29. Conant MA, Opp KM, Poretz D, et al: Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS 11:1300-1301, 1997
30. Murphy M, Armstrong D, Sepkowitz KA, et al: Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor. AIDS 11:261-262, 1997
31. Bernstein ZP, Cohen P, Rios A, et al: A multicenter phase II/III study of atragen (tretinoin liposomal) in patients with AIDS-associated Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 14:A19, 1997 (abstr)